Profound Medical Corp (PROF): Kapitalisasi marang pendapatan
The competitive advantage of Profound Medical Corp. (PROF) is based on clinical efficacy and the training of physicians in prostate therapy methods. By analyzing the price-to-sales ratio on GURU.Markets, we observe that 11.60 reflects the baseline level of this metric. Growth potential is driven by high-margin consumables and a unique synthesis of software and hardware patents, which create significant barriers to entry for new players in the robotic ablation segment.
Rincian analitis perusahaan Profound Medical Corp. (PROF)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- indikator nilai buku ekuitas:
- statistik kawajiban utang lan likuiditas:
Koefisien Total Utang marang Modal Profound Medical Corp.|PROF - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas profoundmedical.com|PROF - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Profound Medical Corporation|PROF - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Profound Medical|Rasio jangkoan perantara profoundmedical.com
- data bathi lan kelipatan valuasi:
PROF - Bathi resik|Bathi resik sing dikarepake Profound Medical Corp.|PROF - Rasio rega marang bathi|Pangali forward rega marang bathi profoundmedical.com|PROF - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Profound Medical Corporation|PROF - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Profound Medical|PROF - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan profoundmedical.com|PROF - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Profound Medical Corp.
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:PROF Profound Medical Corp
To identify undervalued assets, an investor must compare market capitalization with the actual cash flow from sales. This multiple measures the cost per unit of revenue, which is critically important for Profound Medical Corp. (PROF) when assessing the adoption rates of the TULSA-PRO system and the growth of consumables sales, reflecting the current market revaluation through the company's smoothed P/S ratio.
Pesaing Profound Medical Corp.
DXCM (dexcom.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Penumbra PEN|NOVT - Kapitalisasi marang pendapatan|Haemonetics Corp. - Multiplikator P/S|Rega marang dodolan Inspire Medical Systems Inc|PRCT: Multiplikator P/S|Rasio kapitalisasi marang pendapatan CNMD|PLSE (Pulse Biosciences) - Multiplikator P/S|InMode Ltd (INMD) - Koefisien rega marang pendapatan|Multiplikator P/S PMI|Kapitalisasi marang pendapatan Surmodics Inc. SRDX|Multiplikator P/S SENS (Senseonics Holdings)|Multiplikator P/S neuropace.com NPCE|TCMD - Rasio rega marang pendapatan|SNWV: Rasio rega marang pendapatan|OM (Outset) - Kapitalisasi marang pendapatan|Electromed - Rasio kapitalisasi pasar marang pendapatan|LNSR (LENSAR, Inc.) - Multiplikator P/S|Rega marang dodolan avitamedical.com RCEL|Rasio rega marang pendapatan Baird Medical Investment (BDMD)|edap-tms.com (EDAP) - Multiplikator rega marang pendapatan|Apyx Medical Corporation - Kapitalisasi marang pendapatan|Multiplikator P/S IceCure Medical Ltd. ICCM|Pulmonx Corp. - Multiplikator P/S|Koefisien rega marang pendapatan TELA Bio, Inc. TELA|cytosorbents.com (CTSO) - Rasio rega marang pendapatan|Rasio rega marang dodolan SRTS (Sensus Healthcare Inc)|Rasio rega marang pendapatan Zynex Inc|Kapitalisasi marang pendapatan electroCore Medical (ECOR)|Multiplikator P/S RBOT|IINN - Rega marang dodolan|Rasio rega marang pendapatan SeaStar Medical ICU|IRIX: Rasio kapitalisasi marang pendapatan|INBS: Kapitalisasi marang pendapatan|Beyond Air, Inc. - Kapitalisasi marang volume dodolan|Profusa Inc (PFSA) - Rasio rega marang pendapatan|Rasio rega marang dodolan SSKN (STRATA Skin Sciences, Inc.)|Rasio rega marang pendapatan GlucoTrack, Inc.|NAOV: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Venus Concept Corp (VERO)|NUWE - Rega marang dodolan|Multiplikator P/S AEMD (Aethlon Medical)|ASXC (Asensus Surgical Inc) - Rasio rega marang dodolan|AVGR - Rasio rega marang pendapatan|Rega marang dodolan BioSig|CUTR (Cutera, Inc) - Kapitalisasi marang pendapatan|Know Labs Corporation (KNW) - Multiplikator P/S|Rasio rega marang pendapatan Inari Medical, Inc.|Rasio kapitalisasi marang pendapatan NVRO (nevro.com)|Multiplikator P/S RSLS|Silk Road Medical, Inc. - Rasio kapitalisasi marang pendapatan
